Journal of Antimicrobial Chemotherapy 2023

3 papers
The 2023 edition of the Journal of Antimicrobial Chemotherapy featured research focused on optimizing antibiotic use and improving diagnostic accuracy. Key studies examined the clinical consequences of discordant antibiotic therapy in community-onset urinary tract infections, highlighting the relationship between treatment selection and patient outcomes. Additionally, research addressed drug safety through the development of risk prediction models for linezolid-induced thrombocytopenia, utilizing concentrations of the drug and its metabolites to anticipate adverse effects. Methodological consistency in laboratory settings was another prominent theme. An international multi-site study evaluated the performance of penicillin susceptibility testing for Staphylococcus aureus, emphasizing the importance of standardized diagnostic protocols. Prolific contributors during this period included researchers such as Andrew Hayward, Laura Shallcross, Fang Chen, and Hongzhi Xue. Collectively, these works reflect a focus on clinical pharmacology, antimicrobial stewardship, and the refinement of laboratory techniques to guide effective treatment strategies.

Top Research Directions

The 8 research directions with Journal of Antimicrobial Chemotherapy 2023 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.

#DirectionPapersShare
1Countering the Molecular Mechanisms of Antibiotic Resistance133.3%
2Generalizing Clinical Machine Learning Beyond Single Center Cohorts133.3%
3Harmonizing Heterogeneous Clinical Data Streams133.3%
4High-Throughput Protein Quantification via Tandem Mass Spectrometry133.3%
5Isolating Independent Effects with Multivariate Covariate Adjustment133.3%
6Mechanisms of Metabolic Drug-Drug Interactions133.3%
7Residual Confounding in Observational Research133.3%
8Resolving Incomplete Spectral Libraries in Untargeted Metabolomics133.3%

Download all directions as CSV

Institutions

Institutions credited by Journal of Antimicrobial Chemotherapy 2023 papers: a paper credits every institution named in its affiliations, once. 5 institutions share 2 credited papers.

#InstitutionPapersShare
102cdyrc89 150.0%
2Barts Health NHS Trust 150.0%
3Nanjing Medical University 150.0%
4Queen Mary University of London 150.0%
5University College London 150.0%

Download all institutions as CSV

About this data

Papers. Journal of Antimicrobial Chemotherapy 2023 lists 3 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 2 of 3 papers (66.7%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Journal of Antimicrobial Chemotherapy 2023”, https://lacuna.tiptreesystems.com/venue/journal-of-antimicrobial-chemotherapy/2023.

Papers

Title
A multi-site, international laboratory study to assess the performance of penicillin susceptibility testing of Staphylococcus aureus
Assessing the impact of discordant antibiotic treatment on adverse outcomes in community-onset UTI: a retrospective cohort study
Establishment and validation of a risk prediction model incorporating concentrations of linezolid and its metabolite PNU142300 for linezolid-induced thrombocytopenia